Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Availability of Therapies and Services for Parkinson's Disease in Africa: A Continent-Wide Survey
Movement Disorders, Volume 36, No. 10, Year 2021
Notification
URL copied to clipboard!
Description
Background: The growing burden of Parkinson's disease (PD) in Africa necessitates the identification of available therapies and services to improve patient care. Objective: To investigate the availability, affordability, frequency of usage, and insurance coverage of PD therapies (pharmacological, surgical, physical, and speech therapies) and services including specialized clinics, specialists, and nurses across Africa. Methods: A comprehensive web-based survey was constructed and distributed to neurologists/physicians with a special interest in PD across Africa. The survey instrument includes components that address availability, affordability, frequency of use, and insurance coverage of different therapies and services. Results: Responses were received from 28 (of 43 contacted) countries. Levodopa-based oral preparations were always available in 13 countries (46.4%) with variable affordability and “partial or no” insurance coverage in 60% of countries. Bromocriptine was the most available (50%) and affordable ergot dopamine agonists (DA), whereas non-ergot DA was always available in only six countries (21.4%). Trihexyphenidyl was the most available and affordable anticholinergic drug (46.4%). Tricyclic antidepressants and selective serotonin reuptake inhibitors were available in most countries (89.3% and 85.7% respectively), with variable affordability. Quetiapine and clozapine were less available. Specialized clinics and nurses were available in 25% and 7.1% of countries surveyed, respectively. Other services were largely unavailable in the countries surveyed. Conclusion: PD-specific therapies and services are largely unavailable and unaffordable in most African countries. The data provide a platform for organizing strategies to initiate or scale up existing services and drive policies aimed at improving access to care and tailoring education programs in Africa. © 2021 International Parkinson and Movement Disorder Society.
Authors & Co-Authors
Hamid, Eman
Egypt, Cairo
Faculty of Medicine - Ain Shams University
Ayele, Biniyam Alemayehu
Ethiopia, Addis Ababa
School of Medicine
Gams Massi, Daniel
Cameroon, Buea
University of Buea
Ben Sassi, Samia
Tunisia, Tunis
Institut National de Neurologie Mongi-ben Hamida
Tibar, Houyam
Morocco, Guelmim
Regional Hospital of Guelmim
Djonga, Emmanuel Epenge
Democratic Republic Congo, Kinshasa
Neuropsychopathologic Center
El-Sadig, Sarah Misbah
Sudan, Khartoum
Soba University Hospital
Amer El Khedoud, Wahiba
Algeria, Algiers
Etablissement Hospitalier Spécialisé de Ben Aknoun
Razafimahefa, Julien
Madagascar, Antananarivo
University Hospital Joseph Raseta Befelatanana
Kouamé-Assouan, Ange Éric
Cote D'ivoire, Bouake
Bouake Teaching Hospital
Ben-Adji, Djibrilla Wazir
Niger, Maradi
Hôpital Régional de Maradi
Lengane, Y. T.M.
Burkina Faso, Ouagadougou
Hôpital Saint Camille de Ouagadougou
Musubire, Abdu Kisekka
Uganda, Kampala
Kiruddu National Referral Hospital
Mohamed, Muhyadin Hassan
Somalia, Bossaso
East Africa University Hospital
Phiri, Tiwonge Elisa
Malawi, Blantyre
Queen Elizabeth Central Hospital Malawi
Nestor, Nsengiyumva
Burundi, Bujumbura
Hope Africa University
Alwahchi, Wael Abdulgader
Libya, Tripoli
Ali Omar Askar
Neshuku, Saara Ndinelago
Namibia, Windhoek
Katutura State Hospital
Ocampo, C.
Botswana, Gaborone
University of Botswana
Sakadi, Foksouna
Chad, N'djamena
University Hospital Center of National Reference
MAIDAL, Mouled ALI
Djibouti
Specialized Care Center/ Cnss
Ngwende, Gift Wilson
Zimbabwe, Harare
University of Zimbabwe
Hooker, Juzar
Kenya, Nairobi
Aga Khan University Hospital, Nairobi
Okeng'o, Kigocha
Tanzania, Dar es Salaam
Muhimbili National Hospital
Charway-Felli, Augustina
Ghana, Accra
37 Military Hospital
Atadzhanov, Masharip
Zambia, Lusaka
University of Zambia
Carr, Jonathan A.
South Africa, Stellenbosch
Stellenbosch University
Okubadejo, Njideka U.
Nigeria, Lagos
College of Medicine, University of Lagos
Shalash, Ali Soliman
Unknown Affiliation
Statistics
Citations: 29
Authors: 29
Affiliations: 28
Identifiers
Doi:
10.1002/mds.28669
ISSN:
08853185
e-ISSN:
15318257
Research Areas
Health System And Policy
Substance Abuse
Study Design
Cross Sectional Study
Study Approach
Quantitative